Other commonly used CSF biomarkers for AD—t-tau, Aβ42, Aβ42/Aβ40 ratio, and p-tau T217/t-tau ratio—showed worse diagnostic performance than p-tau pT217 alone (figure 4, C–F). Here, MAPT is linked to Alzheimer disease.